NFKB1 and atherosclerosis: Our results revealed that inhibition of NEMO-dependent canonical NF-κB signalling in SMCs substantially inhibited the development of atherosclerotic plaques, demonstrating a critical pathogenic role of NF-κB signalling in SMCs in atherosclerosis.